Literature DB >> 15788447

Hepatic leptin signaling in obesity.

Georg Brabant1, Günter Müller, Rüdiger Horn, Christian Anderwald, Michael Roden, Heike Nave.   

Abstract

Obesity, a state of apparent "leptin resistance" is well known to be associated with insulin resistance. In diet-induced obesity (DIO), hepatic insulin signaling is impaired but the link between leptin and insulin signaling pathways is only incompletely defined. The aim of the present study was to evaluate the effects of DIO on leptin and insulin cross-signaling in the liver. Leptin receptor expression was measured by in situ hybridization with pan-leptin receptor probes and by immunoblotting. Furthermore, intracellular signaling was investigated in vivo under basal conditions and at 45 and 360 min after stimulation with a bolus of human recombinant leptin (hrec-leptin; 1 mg/kg body wt) or saline. At baseline, all forms of the leptin receptor were markedly to completely down-regulated in DIO rats. Hrec-leptin bolus injection stimulated leptin-dependent signaling with a fivefold increase in JAK-2pY in lean but not in DIO rats. Basal IRpY, IRS-1pY, IRS-1p85, IRS-2pY, IRSp85, and PKBpT308 levels were reduced (P<0.01) in DIO rats as compared with lean controls. Basal GSK-3beta serine phosphorylation (S9) was higher (P<0.01) in lean animals along with lower basal PEPCK activity compared with DIO rats consistent with the insulin and leptin resistance of the latter. Only in lean animals phosphorylation of PKB (T308) and GSK-3beta (S9) was acutely stimulated by leptin at 45 min followed by inhibition at 6 h after application. AMPKalpha protein levels as well as basal and leptin-stimulated total and alpha-specific AMPK activity were comparable in both groups. These data show that in a model of dietary-induced obesity 1) leptin receptors and subsequent signaling events are down-regulated, 2) basal insulin signaling is impaired, and 3) the cross-talk between leptin and insulin signaling is differentially regulated by the nutritional status, which is sensed by AMPK in rat liver. Thus, the liver seems to play a major role in the modulation of the leptin signal and insulin resistance in obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788447     DOI: 10.1096/fj.04-2846fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  29 in total

1.  Hepatic glucose production and insulin resistance.

Authors:  Michael Roden
Journal:  Wien Med Wochenschr       Date:  2008

2.  Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.

Authors:  Licht Miyamoto; Ken Ebihara; Toru Kusakabe; Daisuke Aotani; Sachiko Yamamoto-Kataoka; Takeru Sakai; Megumi Aizawa-Abe; Yuji Yamamoto; Junji Fujikura; Tatsuya Hayashi; Kiminori Hosoda; Kazuwa Nakao
Journal:  J Biol Chem       Date:  2012-09-28       Impact factor: 5.157

Review 3.  Biology's response to dieting: the impetus for weight regain.

Authors:  Paul S Maclean; Audrey Bergouignan; Marc-Andre Cornier; Matthew R Jackman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

4.  Decrease in hepatic very-low-density lipoprotein-triglyceride secretion after weight loss is inversely associated with changes in circulating leptin.

Authors:  F Magkos; E Fabbrini; J McCrea; B W Patterson; J C Eagon; S Klein
Journal:  Diabetes Obes Metab       Date:  2010-07       Impact factor: 6.577

5.  Long-term plasma ghrelin and leptin modulation after sleeve gastrectomy in Wistar rats in comparison with gastric tissue ghrelin expression.

Authors:  Panagiotis Patrikakos; Konstantinos G Toutouzas; Maria Gazouli; Despoina Perrea; Evangelos Menenakos; Stefanos Papadopoulos; George Zografos
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

6.  Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.

Authors:  C Owen; E K Lees; L Grant; D J Zimmer; N Mody; K K Bence; M Delibegović
Journal:  Diabetologia       Date:  2013-07-06       Impact factor: 10.122

7.  Leptin and incident type 2 diabetes: risk or protection?

Authors:  M I Schmidt; B B Duncan; A Vigo; J S Pankow; D Couper; C M Ballantyne; R C Hoogeveen; G Heiss
Journal:  Diabetologia       Date:  2006-07-19       Impact factor: 10.122

8.  Hepatic PTP1B Deficiency: The Promise of a Treatment for Metabolic Syndrome?

Authors:  Kendra K Bence
Journal:  J Clin Metab Diabetes       Date:  2010-05

9.  Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure.

Authors:  Wenzhong Liu; Rajvir Singh; Cheol Soo Choi; Hui-Young Lee; Ali R Keramati; Varman T Samuel; Richard P Lifton; Gerald I Shulman; Arya Mani
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

10.  Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis.

Authors:  Jun Liu; Liuwei Gao; Hua Zhang; Daowei Wang; Meng Wang; Jianquan Zhu; Cong Pang; Changli Wang
Journal:  J Biol Chem       Date:  2013-08-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.